Sandbox sss: Difference between revisions
Jump to navigation
Jump to search
Line 59: | Line 59: | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''AND'' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''AND'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefotaxime]] 1 gm q8–12h to 2 gm IV q4h''''' <BR>''OR''<BR> ▸ '''''[[Ceftriaxone]] 1 gm IV qd''OR'' 2 g IV q12h(for Purulent meningitis also IM in 1% lidocaine)''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefotaxime]] 1 gm q8–12h to 2 gm IV q4h''''' <BR>''OR''<BR> ▸ '''''[[Ceftriaxone]] 1 gm IV qd ''OR'' 2 g IV q12h(for Purulent meningitis also IM in 1% lidocaine)'''''<sup>Ω<sup> | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen'' | ||
Line 67: | Line 67: | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''AND'' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''AND'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Moxifloxacin]] 400 mg po IV q24h ''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Moxifloxacin]] 400 mg po IV q24h '''''<sup>ɸ<sup> | ||
|- | |- | ||
|} | |} |
Revision as of 20:29, 16 January 2014
Meningitis Main Page |
Streptococcus pneumoniae
|
|
Neisseria meningitidis
|
|
Listeria Monocytogenes and Streptococcus agalactiae
|
|
Haemophilus influenzae
|
|
Staphylococcus aureus
|
|
Staphylococcus epidermidis and Acinetobacter baumannii
Enterobacteriaceae and Pseudomonas aeruginosa
|